Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Powershares DWA Developed Markets Momentum Portf	PIZ	5. nov 2024	37.44	+0.83
Powershares DWA Emerging Markets Momentum Portfo	PIE	5. nov 2024	20.25	+0.78
Powershares DWA Momentum Portfolio	PDP	5. nov 2024	105.76	+2.35
Powershares DWA Smallcap Momentum Portfolio	DWAS	5. nov 2024	94.05	+1.85
Powershares Global Short Term H	PGHY	5. nov 2024	19.95	+0.21
PowerShares International BuyBack Achievers Portfolio	IPKW	5. nov 2024	42.38	+0.80
Powershares QQQ	QQQ	5. nov 2024	492.21	+1.28
Powershares S&P 500 Downside He	PHDG	5. nov 2024	37.87	-0.21
Powershares S&P 500 High Divide	SPHD	5. nov 2024	49.99	+0.83
Powershares S&P Midcap Low Vola	XMLV	5. nov 2024	61.55	+1.30
Powershares S&P Smallcap Low Vo	XSLV	5. nov 2024	47.91	+1.63
PowerShares Variable Rate Investment Grade Portfolio	VRIG	5. nov 2024	25.12	+0.04
PowerUp Acquisition A	PWUP	5. nov 2024	11.40	-0.09
PowerUp Acquisition Unit	PWUPU	5. nov 2024	11.41	-0.26
PPG Industries	PPG	5. nov 2024	124.65	-0.17
PPL	PPL	5. nov 2024	32.59	+1.65
PRA Group	PRAA	5. nov 2024	23.83	+15.90
Prairie Operating	PROP	5. nov 2024	8.62	-0.46
Praxis Precision Medicines	PRAX	5. nov 2024	72.73	+3.87
Precigen	PGEN	5. nov 2024	0.82	+1.28
Precipio	PRPO	5. nov 2024	6.20	+0.81
Precision BioSciences	DTIL	5. nov 2024	8.46	+2.05
Precision Drilling	PDS	5. nov 2024	61.91	+0.93
Precision Optics	POCI	5. nov 2024	4.31	+3.36
Predictive Oncology	POAI	5. nov 2024	0.70	+2.73
Preferred Bank	PFBC	5. nov 2024	84.83	+2.01
Preferred Portfolio Powershares	PGX	5. nov 2024	12.24	+0.74
Preformed Line Products	PLPC	5. nov 2024	123.33	-1.20
Prelude Therapeutics	PRLD	5. nov 2024	1.29	+7.50
Premier A	PINC	5. nov 2024	22.67	+13.29

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.